Institutional Ownership Eagle Pharmaceuticals, Inc. (EGRX)
This table provides information about the institutional ownership of Eagle Pharmaceuticals, Inc. (EGRX). We have compiled data on the 70 institutions that hold shares in the stock, with a total of 8.6 Million shares, which have been reported (via 13F filing form) to have a value of $5.59 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nantahala Capital Management, LLC
New Canaan, CT |
Nov 14, 2024 Q3 2024 |
2,356,536
shares
|
$1.53 Million
0.52% of portfolio
|
Q3 2024
Added 20.1%
|
|
|
Aigh Capital Management LLC
Baltimore, MD |
Nov 13, 2024 Q3 2024 |
1,211,509
shares
|
$787,480
1.82% of portfolio
|
Q2 2024
Added 2.11%
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
1,000,389
shares
|
$650,252
0.0% of portfolio
|
Q3 2024
Reduced 0.12%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
579,507
shares
|
$376,679
0.0% of portfolio
|
Q3 2024
Added 2.68%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2024 Q3 2024 |
374,992
shares
|
$243,744
0.0% of portfolio
|
Q3 2024
Reduced 46.18%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
352,762
shares
|
$229,295
0.0% of portfolio
|
Q2 2024
Reduced 60.71%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Nov 13, 2024 Q3 2024 |
256,350
shares
|
$166,627
0.0% of portfolio
|
Q3 2024
Added 4.95%
|
|
|
Marshall Wace, LLP
London, X0 |
Nov 14, 2024 Q3 2024 |
223,353
shares
|
$145,179
0.0% of portfolio
|
Q3 2024
Added 14.26%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
192,213
shares
|
$124,938
0.0% of portfolio
|
Q3 2024
Reduced 36.02%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
185,058
shares
|
$120,287
0.0% of portfolio
|
Q3 2024
Reduced 17.69%
|
|
|
Assenagon Asset Management S.A.
|
Oct 23, 2024 Q3 2024 |
183,592
shares
|
$119,334
0.0% of portfolio
|
Q3 2024
Reduced 0.94%
|
|
|
J. Goldman & CO LP
New York, NY |
Nov 14, 2024 Q3 2024 |
150,611
shares
|
$97,897
0.02% of portfolio
|
Q3 2024
Reduced 21.19%
|
|
|
Rbf Capital, LLC
San Francisco, CA |
Nov 14, 2024 Q3 2024 |
143,078
shares
|
$93,000
0.03% of portfolio
|
Q3 2024
Added 11.7%
|
|
|
Jacobs Levy Equity Management, Inc
Florham Park, NJ |
Nov 14, 2024 Q3 2024 |
121,559
shares
|
$79,013
0.0% of portfolio
|
Q3 2024
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
119,312
shares
|
$77,552
0.0% of portfolio
|
Q3 2024
Reduced 10.92%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
118,857
shares
|
$77,257
0.04% of portfolio
|
Q2 2023
Added 48.57%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
105,846
shares
|
$68,799
0.0% of portfolio
|
Q3 2024
Reduced 2.0%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
82,775
shares
|
$53,803
0.0% of portfolio
|
Q3 2024
Added 0.43%
|
|
|
Dgs Capital Management, LLC
|
Dec 10, 2024 Q3 2024 |
71,728
shares
|
$46,623
0.07% of portfolio
|
Q3 2024
Added 44.94%
|
|
|
Union Square Park Capital Management, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
56,963
shares
|
$37,025
0.16% of portfolio
|
Q3 2024
New holding
|
|
|
Ajo Vista, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
56,438
shares
|
$36,684
0.92% of portfolio
|
Q3 2024
Added 402.48%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
54,625
shares
|
$35,506
0.0% of portfolio
|
Q3 2024
Reduced 68.06%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
51,006
shares
|
$33,153
0.0% of portfolio
|
Q3 2024
Reduced 84.33%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
48,800
shares
|
$31,720
0.0% of portfolio
|
Q4 2023
Added 755.69%
|
|
|
Trexquant Investment LP
Stamford, CT |
Nov 12, 2024 Q3 2024 |
43,723
shares
|
$28,419
0.0% of portfolio
|
Q3 2024
Reduced 17.43%
|